Prognostic Implications of Gene Mutations in Acute Myeloid Leukemia With Normal Cytogenetics
Authors:
- Konstanze DöhnerKDKonstanze Döhner
- 1 August 2008
- journal article
- review article
- Published by Elsevier in Seminars in Oncology
- Vol. 35 (4) , 346-355
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Acute myeloid leukaemiaThe Lancet, 2006
- Genetics of Myeloid Malignancies: Pathogenetic and Clinical ImplicationsJournal of Clinical Oncology, 2005
- Prognostic Factors and Outcome of Core Binding Factor Acute Myeloid Leukemia Patients With t(8;21) Differ From Those of Patients With inv(16): A Cancer and Leukemia Group B StudyJournal of Clinical Oncology, 2005
- Individual Patient Data–Based Meta-Analysis of Patients Aged 16 to 60 Years With Core Binding Factor Acute Myeloid Leukemia: A Survey of the German Acute Myeloid Leukemia IntergroupJournal of Clinical Oncology, 2004
- Cytogenetics in acute leukemiaBlood Reviews, 2004
- Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid LeukemiaJournal of Clinical Oncology, 2003
- GENETICS OF MYELOID LEUKEMIASAnnual Review of Genomics and Human Genetics, 2002
- Clinical importance of cytogenetics in acute myeloid leukaemiaBest Practice & Research Clinical Haematology, 2001
- The fusion gene Cbfb-MYH11 blocks myeloid differentiation and predisposes mice to acute myelomonocytic leukaemiaNature Genetics, 1999
- All-trans-Retinoic Acid in Acute Promyelocytic LeukemiaNew England Journal of Medicine, 1997